Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Wegovy is FDA-approved for weight management in adults with a BMI of 30, or 27 with weight related comorbidities
Unlike higher doses of Semaglutide that are typically prescribed for diabetes or weight loss, Microdosing GLP-1 focuses on broader health and longevity benefits with reduced side effects: Lower dose Microdosing GLP-1 uses very low doses
On the contrary, a systematic review on mortality, as well as cardiovascular and kidney statuses in patients with T2DM treated with GLP-1RAs concluded that there was no increase in the incidence of severe hypoglycaemia, pancreatitis, or pancreatic cancer (222)
Month 3 (Weeks 8-12 post-last injection): Cycles are typically stabilizing by now as hormones adjust to your new body weight
